nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—endothelium—malignant glioma	0.0239	0.0756	CbGeAlD
Amiloride—PLAU—blood vessel—malignant glioma	0.0221	0.0697	CbGeAlD
Amiloride—ASIC2—telencephalon—malignant glioma	0.0186	0.0589	CbGeAlD
Amiloride—ASIC2—medulla oblongata—malignant glioma	0.0147	0.0462	CbGeAlD
Amiloride—AOC1—embryo—malignant glioma	0.0145	0.0458	CbGeAlD
Amiloride—SLC9A1—embryo—malignant glioma	0.0139	0.0438	CbGeAlD
Amiloride—SCNN1D—telencephalon—malignant glioma	0.012	0.0379	CbGeAlD
Amiloride—ASIC1—telencephalon—malignant glioma	0.0118	0.0372	CbGeAlD
Amiloride—SLC9A1—telencephalon—malignant glioma	0.0113	0.0357	CbGeAlD
Amiloride—ASIC2—central nervous system—malignant glioma	0.0106	0.0335	CbGeAlD
Amiloride—ASIC2—cerebellum—malignant glioma	0.0104	0.0327	CbGeAlD
Amiloride—SCNN1A—telencephalon—malignant glioma	0.00938	0.0296	CbGeAlD
Amiloride—ASIC1—medulla oblongata—malignant glioma	0.00927	0.0293	CbGeAlD
Amiloride—ASIC1—midbrain—malignant glioma	0.00847	0.0267	CbGeAlD
Amiloride—ASIC2—brain—malignant glioma	0.00841	0.0266	CbGeAlD
Amiloride—ASIC1—spinal cord—malignant glioma	0.00826	0.0261	CbGeAlD
Amiloride—SLC9A1—midbrain—malignant glioma	0.00811	0.0256	CbGeAlD
Amiloride—SCNN1D—central nervous system—malignant glioma	0.00683	0.0216	CbGeAlD
Amiloride—ASIC1—central nervous system—malignant glioma	0.0067	0.0212	CbGeAlD
Amiloride—SCNN1D—cerebellum—malignant glioma	0.00668	0.0211	CbGeAlD
Amiloride—SCNN1G—cerebellum—malignant glioma	0.00668	0.0211	CbGeAlD
Amiloride—ASIC1—cerebellum—malignant glioma	0.00655	0.0207	CbGeAlD
Amiloride—Encephalopathy—Carmustine—malignant glioma	0.00646	0.0428	CcSEcCtD
Amiloride—SLC9A1—central nervous system—malignant glioma	0.00642	0.0203	CbGeAlD
Amiloride—SLC9A1—cerebellum—malignant glioma	0.00628	0.0198	CbGeAlD
Amiloride—PLAU—central nervous system—malignant glioma	0.00609	0.0192	CbGeAlD
Amiloride—Digestion impaired—Temozolomide—malignant glioma	0.006	0.0397	CcSEcCtD
Amiloride—SCNN1B—central nervous system—malignant glioma	0.00577	0.0182	CbGeAlD
Amiloride—SCNN1D—brain—malignant glioma	0.00542	0.0171	CbGeAlD
Amiloride—ASIC1—brain—malignant glioma	0.00532	0.0168	CbGeAlD
Amiloride—SLC9A1—brain—malignant glioma	0.0051	0.0161	CbGeAlD
Amiloride—PLAU—brain—malignant glioma	0.00483	0.0153	CbGeAlD
Amiloride—SCNN1B—brain—malignant glioma	0.00458	0.0145	CbGeAlD
Amiloride—SCNN1A—brain—malignant glioma	0.00423	0.0134	CbGeAlD
Amiloride—Neck pain—Carmustine—malignant glioma	0.0042	0.0278	CcSEcCtD
Amiloride—Coma—Carmustine—malignant glioma	0.00379	0.0251	CcSEcCtD
Amiloride—Aplastic anaemia—Temozolomide—malignant glioma	0.00376	0.0249	CcSEcCtD
Amiloride—Gynaecomastia—Carmustine—malignant glioma	0.00371	0.0246	CcSEcCtD
Amiloride—SLC22A1—telencephalon—malignant glioma	0.00358	0.0113	CbGeAlD
Amiloride—Nasal congestion—Temozolomide—malignant glioma	0.00319	0.0212	CcSEcCtD
Amiloride—Thirst—Temozolomide—malignant glioma	0.00306	0.0203	CcSEcCtD
Amiloride—Hyponatraemia—Carmustine—malignant glioma	0.00302	0.02	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00301	0.02	CcSEcCtD
Amiloride—Muscular weakness—Carmustine—malignant glioma	0.00266	0.0176	CcSEcCtD
Amiloride—SLC22A4—spinal cord—malignant glioma	0.00263	0.00831	CbGeAlD
Amiloride—Muscular weakness—Temozolomide—malignant glioma	0.00257	0.017	CcSEcCtD
Amiloride—Abdominal distension—Temozolomide—malignant glioma	0.00253	0.0168	CcSEcCtD
Amiloride—Neutropenia—Carmustine—malignant glioma	0.00243	0.0161	CcSEcCtD
Amiloride—Dysuria—Temozolomide—malignant glioma	0.00235	0.0156	CcSEcCtD
Amiloride—Neutropenia—Temozolomide—malignant glioma	0.00235	0.0156	CcSEcCtD
Amiloride—Pollakiuria—Temozolomide—malignant glioma	0.00232	0.0154	CcSEcCtD
Amiloride—Erectile dysfunction—Temozolomide—malignant glioma	0.00232	0.0154	CcSEcCtD
Amiloride—Depression—Carmustine—malignant glioma	0.00231	0.0153	CcSEcCtD
Amiloride—Depression—Temozolomide—malignant glioma	0.00224	0.0148	CcSEcCtD
Amiloride—Haemoglobin—Carmustine—malignant glioma	0.00209	0.0139	CcSEcCtD
Amiloride—SLC22A4—cerebellum—malignant glioma	0.00209	0.00659	CbGeAlD
Amiloride—Haemorrhage—Carmustine—malignant glioma	0.00208	0.0138	CcSEcCtD
Amiloride—SLC22A1—central nervous system—malignant glioma	0.00203	0.00642	CbGeAlD
Amiloride—Haemoglobin—Temozolomide—malignant glioma	0.00202	0.0134	CcSEcCtD
Amiloride—Haemorrhage—Temozolomide—malignant glioma	0.00201	0.0133	CcSEcCtD
Amiloride—Visual impairment—Carmustine—malignant glioma	0.00201	0.0133	CcSEcCtD
Amiloride—Visual impairment—Temozolomide—malignant glioma	0.00194	0.0129	CcSEcCtD
Amiloride—Tinnitus—Temozolomide—malignant glioma	0.00188	0.0124	CcSEcCtD
Amiloride—Alopecia—Carmustine—malignant glioma	0.00184	0.0122	CcSEcCtD
Amiloride—Alopecia—Temozolomide—malignant glioma	0.00178	0.0118	CcSEcCtD
Amiloride—Back pain—Carmustine—malignant glioma	0.00175	0.0116	CcSEcCtD
Amiloride—Tremor—Carmustine—malignant glioma	0.0017	0.0113	CcSEcCtD
Amiloride—SLC22A4—brain—malignant glioma	0.0017	0.00535	CbGeAlD
Amiloride—Back pain—Temozolomide—malignant glioma	0.0017	0.0112	CcSEcCtD
Amiloride—Tremor—Temozolomide—malignant glioma	0.00164	0.0109	CcSEcCtD
Amiloride—SLC22A1—brain—malignant glioma	0.00161	0.0051	CbGeAlD
Amiloride—Vertigo—Temozolomide—malignant glioma	0.00157	0.0104	CcSEcCtD
Amiloride—Palpitations—Temozolomide—malignant glioma	0.00155	0.0103	CcSEcCtD
Amiloride—Chest pain—Carmustine—malignant glioma	0.00154	0.0102	CcSEcCtD
Amiloride—Cough—Temozolomide—malignant glioma	0.00153	0.0101	CcSEcCtD
Amiloride—Confusional state—Carmustine—malignant glioma	0.00149	0.00989	CcSEcCtD
Amiloride—Arthralgia—Temozolomide—malignant glioma	0.00149	0.00989	CcSEcCtD
Amiloride—Confusional state—Temozolomide—malignant glioma	0.00144	0.00956	CcSEcCtD
Amiloride—Anorexia—Carmustine—malignant glioma	0.00141	0.00935	CcSEcCtD
Amiloride—Anorexia—Temozolomide—malignant glioma	0.00136	0.00903	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00135	0.00894	CcSEcCtD
Amiloride—Insomnia—Carmustine—malignant glioma	0.00134	0.00887	CcSEcCtD
Amiloride—Paraesthesia—Carmustine—malignant glioma	0.00133	0.00881	CcSEcCtD
Amiloride—Dyspnoea—Carmustine—malignant glioma	0.00132	0.00874	CcSEcCtD
Amiloride—Somnolence—Carmustine—malignant glioma	0.00132	0.00872	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0013	0.00864	CcSEcCtD
Amiloride—Insomnia—Temozolomide—malignant glioma	0.00129	0.00857	CcSEcCtD
Amiloride—Decreased appetite—Carmustine—malignant glioma	0.00129	0.00853	CcSEcCtD
Amiloride—Paraesthesia—Temozolomide—malignant glioma	0.00128	0.00851	CcSEcCtD
Amiloride—Gastrointestinal disorder—Carmustine—malignant glioma	0.00128	0.00847	CcSEcCtD
Amiloride—Dyspnoea—Temozolomide—malignant glioma	0.00128	0.00845	CcSEcCtD
Amiloride—Somnolence—Temozolomide—malignant glioma	0.00127	0.00843	CcSEcCtD
Amiloride—Pain—Carmustine—malignant glioma	0.00127	0.00839	CcSEcCtD
Amiloride—Constipation—Carmustine—malignant glioma	0.00127	0.00839	CcSEcCtD
Amiloride—Dyspepsia—Temozolomide—malignant glioma	0.00126	0.00834	CcSEcCtD
Amiloride—Decreased appetite—Temozolomide—malignant glioma	0.00124	0.00824	CcSEcCtD
Amiloride—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00123	0.00818	CcSEcCtD
Amiloride—Fatigue—Temozolomide—malignant glioma	0.00123	0.00817	CcSEcCtD
Amiloride—Pain—Temozolomide—malignant glioma	0.00122	0.00811	CcSEcCtD
Amiloride—Constipation—Temozolomide—malignant glioma	0.00122	0.00811	CcSEcCtD
Amiloride—Feeling abnormal—Carmustine—malignant glioma	0.00122	0.00808	CcSEcCtD
Amiloride—Gastrointestinal pain—Carmustine—malignant glioma	0.00121	0.00802	CcSEcCtD
Amiloride—Feeling abnormal—Temozolomide—malignant glioma	0.00118	0.00781	CcSEcCtD
Amiloride—Abdominal pain—Carmustine—malignant glioma	0.00117	0.00775	CcSEcCtD
Amiloride—Gastrointestinal pain—Temozolomide—malignant glioma	0.00117	0.00775	CcSEcCtD
Amiloride—Abdominal pain—Temozolomide—malignant glioma	0.00113	0.00749	CcSEcCtD
Amiloride—Asthenia—Carmustine—malignant glioma	0.00106	0.00704	CcSEcCtD
Amiloride—Asthenia—Temozolomide—malignant glioma	0.00103	0.0068	CcSEcCtD
Amiloride—Diarrhoea—Carmustine—malignant glioma	0.00101	0.00671	CcSEcCtD
Amiloride—Pruritus—Temozolomide—malignant glioma	0.00101	0.00671	CcSEcCtD
Amiloride—Dizziness—Carmustine—malignant glioma	0.000979	0.00649	CcSEcCtD
Amiloride—Diarrhoea—Temozolomide—malignant glioma	0.000979	0.00649	CcSEcCtD
Amiloride—Dizziness—Temozolomide—malignant glioma	0.000946	0.00627	CcSEcCtD
Amiloride—Vomiting—Carmustine—malignant glioma	0.000941	0.00624	CcSEcCtD
Amiloride—Rash—Carmustine—malignant glioma	0.000933	0.00618	CcSEcCtD
Amiloride—Dermatitis—Carmustine—malignant glioma	0.000932	0.00618	CcSEcCtD
Amiloride—Headache—Carmustine—malignant glioma	0.000927	0.00614	CcSEcCtD
Amiloride—Vomiting—Temozolomide—malignant glioma	0.000909	0.00603	CcSEcCtD
Amiloride—Rash—Temozolomide—malignant glioma	0.000902	0.00598	CcSEcCtD
Amiloride—Dermatitis—Temozolomide—malignant glioma	0.000901	0.00597	CcSEcCtD
Amiloride—Headache—Temozolomide—malignant glioma	0.000896	0.00594	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—RAF1—malignant glioma	0.000882	0.00166	CbGpPWpGaD
Amiloride—Nausea—Carmustine—malignant glioma	0.000879	0.00583	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—BCL2—malignant glioma	0.000872	0.00164	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MDM2—malignant glioma	0.000859	0.00161	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MYC—malignant glioma	0.000855	0.00161	CbGpPWpGaD
Amiloride—Nausea—Temozolomide—malignant glioma	0.000849	0.00563	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—ERBB2—malignant glioma	0.000847	0.00159	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000846	0.00159	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000846	0.00159	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000846	0.00159	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000846	0.00159	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000846	0.00159	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CB—malignant glioma	0.000836	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	0.000828	0.00155	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CXCL8—malignant glioma	0.000827	0.00155	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—MYC—malignant glioma	0.000827	0.00155	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HIST1H3B—malignant glioma	0.000811	0.00152	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000805	0.00151	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000805	0.00151	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000805	0.00151	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000805	0.00151	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000805	0.00151	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MYB—malignant glioma	0.000804	0.00151	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1B—malignant glioma	0.000794	0.00149	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	0.000792	0.00149	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PTEN—malignant glioma	0.000744	0.0014	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	0.000739	0.00139	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—STAT3—malignant glioma	0.000738	0.00139	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—AKT1—malignant glioma	0.00073	0.00137	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PTEN—malignant glioma	0.000722	0.00136	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	0.000721	0.00136	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—AKT1—malignant glioma	0.000715	0.00134	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—COX8A—malignant glioma	0.000714	0.00134	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—malignant glioma	0.000702	0.00132	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000698	0.00131	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—KRAS—malignant glioma	0.000698	0.00131	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BCAN—malignant glioma	0.000682	0.00128	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—EGFR—malignant glioma	0.00067	0.00126	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000638	0.0012	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—AKT1—malignant glioma	0.000637	0.0012	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—KRAS—malignant glioma	0.000633	0.00119	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—malignant glioma	0.000633	0.00119	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—H3F3A—malignant glioma	0.000626	0.00118	CbGpPWpGaD
Amiloride—SLC9A1—Disease—DTX1—malignant glioma	0.000617	0.00116	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ASMT—malignant glioma	0.000607	0.00114	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000607	0.00114	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—malignant glioma	0.0006	0.00113	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CA—malignant glioma	0.000582	0.00109	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BCAN—malignant glioma	0.000571	0.00107	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000558	0.00105	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000558	0.00105	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—KRAS—malignant glioma	0.000554	0.00104	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000543	0.00102	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000531	0.000997	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—malignant glioma	0.00052	0.000976	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KNG1—malignant glioma	0.000516	0.00097	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—malignant glioma	0.000509	0.000957	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—malignant glioma	0.000508	0.000954	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	0.000507	0.000952	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IFNA2—malignant glioma	0.000506	0.00095	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000505	0.000949	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000502	0.000943	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000497	0.000935	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—malignant glioma	0.000493	0.000926	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HEY2—malignant glioma	0.000484	0.000909	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000481	0.000904	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SOD1—malignant glioma	0.000479	0.000901	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	0.000479	0.000899	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000478	0.000898	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—malignant glioma	0.000475	0.000893	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IDH1—malignant glioma	0.000473	0.000888	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000471	0.000885	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000464	0.000871	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—IDH2—malignant glioma	0.00046	0.000865	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HEY1—malignant glioma	0.000448	0.000842	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PTK2—malignant glioma	0.00044	0.000827	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	0.00044	0.000826	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HIST1H3B—malignant glioma	0.000435	0.000818	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2B6—malignant glioma	0.000433	0.000813	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—malignant glioma	0.000416	0.000782	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JAG2—malignant glioma	0.000397	0.000747	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—IDH1—malignant glioma	0.000396	0.000744	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SPHK1—malignant glioma	0.000383	0.00072	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2C18—malignant glioma	0.000375	0.000705	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PDGFB—malignant glioma	0.00037	0.000695	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000365	0.000685	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000365	0.000685	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000365	0.000685	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000365	0.000685	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000365	0.000685	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CAV1—malignant glioma	0.000351	0.000659	CbGpPWpGaD
Amiloride—SLC9A1—Disease—H3F3A—malignant glioma	0.000336	0.000632	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—F2—malignant glioma	0.000334	0.000627	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—FN1—malignant glioma	0.000334	0.000627	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00033	0.00062	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CG—malignant glioma	0.000319	0.0006	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JAG1—malignant glioma	0.000317	0.000596	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—EGF—malignant glioma	0.000316	0.000593	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PTPN11—malignant glioma	0.000314	0.000589	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FBXW7—malignant glioma	0.000311	0.000583	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000308	0.000578	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTT1—malignant glioma	0.000303	0.00057	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000302	0.000567	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000297	0.000557	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT2—malignant glioma	0.000292	0.000549	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS1—malignant glioma	0.000284	0.000534	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000281	0.000529	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CD—malignant glioma	0.000281	0.000527	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000279	0.000524	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000278	0.000522	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000276	0.000519	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RTEL1—malignant glioma	0.000269	0.000506	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BCHE—malignant glioma	0.000264	0.000497	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000264	0.000496	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC5A5—malignant glioma	0.000261	0.000491	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00026	0.000488	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000257	0.000482	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000255	0.000479	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RTEL1—malignant glioma	0.000251	0.000471	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAF1—malignant glioma	0.000251	0.000471	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000246	0.000462	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CB—malignant glioma	0.000245	0.00046	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN2B—malignant glioma	0.000243	0.000457	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000243	0.000456	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000241	0.000452	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000239	0.000449	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000237	0.000446	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HES1—malignant glioma	0.000232	0.000436	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NCOR1—malignant glioma	0.000231	0.000434	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BCHE—malignant glioma	0.000227	0.000427	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000226	0.000425	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IL2—malignant glioma	0.000225	0.000422	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000221	0.000416	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFRA—malignant glioma	0.000221	0.000415	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—SLC6A3—malignant glioma	0.000214	0.000401	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BCHE—malignant glioma	0.000212	0.000398	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000211	0.000396	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—malignant glioma	0.00021	0.000395	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAT—malignant glioma	0.000205	0.000385	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TERT—malignant glioma	0.000203	0.000382	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HLA-A—malignant glioma	0.000203	0.000382	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—SLC6A3—malignant glioma	0.000199	0.000374	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFB—malignant glioma	0.000199	0.000373	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGFR1—malignant glioma	0.000198	0.000371	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HIF1A—malignant glioma	0.000195	0.000365	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NCOR1—malignant glioma	0.000193	0.000363	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—malignant glioma	0.000191	0.000359	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CAV1—malignant glioma	0.000188	0.000353	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BAD—malignant glioma	0.000177	0.000332	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOTCH1—malignant glioma	0.000175	0.000329	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD80—malignant glioma	0.000172	0.000323	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—malignant glioma	0.000171	0.000322	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGF—malignant glioma	0.000169	0.000318	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTPN11—malignant glioma	0.000168	0.000316	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—malignant glioma	0.000162	0.000305	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BRAF—malignant glioma	0.000161	0.000303	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAV1—malignant glioma	0.000158	0.000296	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT2—malignant glioma	0.000157	0.000295	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COX8A—malignant glioma	0.000155	0.00029	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000151	0.000284	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—malignant glioma	0.000151	0.000283	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—malignant glioma	0.000149	0.00028	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—malignant glioma	0.000144	0.000271	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF2—malignant glioma	0.000144	0.000271	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COX8A—malignant glioma	0.000144	0.000271	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—malignant glioma	0.000144	0.00027	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000141	0.000265	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—malignant glioma	0.000139	0.00026	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MDM2—malignant glioma	0.000135	0.000254	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAF1—malignant glioma	0.000135	0.000253	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—malignant glioma	0.000133	0.00025	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ASMT—malignant glioma	0.000131	0.000247	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000131	0.000247	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—malignant glioma	0.000131	0.000247	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—malignant glioma	0.00013	0.000244	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000127	0.000238	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000126	0.000237	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—malignant glioma	0.000126	0.000237	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCAN—malignant glioma	0.000124	0.000232	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ASMT—malignant glioma	0.000123	0.00023	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000122	0.00023	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—malignant glioma	0.000122	0.000229	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000121	0.000227	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000118	0.000222	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000118	0.000221	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BRAF—malignant glioma	0.000116	0.000218	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCAN—malignant glioma	0.000115	0.000216	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000115	0.000216	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—malignant glioma	0.000113	0.000213	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000112	0.000211	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00011	0.000207	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—malignant glioma	0.00011	0.000207	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—malignant glioma	0.000109	0.000205	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BRAF—malignant glioma	0.000108	0.000203	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000107	0.000201	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—malignant glioma	0.000101	0.000191	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH2—malignant glioma	9.96e-05	0.000187	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MDM2—malignant glioma	9.72e-05	0.000183	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—RAF1—malignant glioma	9.68e-05	0.000182	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—malignant glioma	9.5e-05	0.000179	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—malignant glioma	9.43e-05	0.000177	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2B6—malignant glioma	9.37e-05	0.000176	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH2—malignant glioma	9.29e-05	0.000174	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—malignant glioma	9.22e-05	0.000173	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MDM2—malignant glioma	9.06e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—RAF1—malignant glioma	9.02e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2B6—malignant glioma	8.73e-05	0.000164	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—malignant glioma	8.71e-05	0.000164	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH1—malignant glioma	8.57e-05	0.000161	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SPHK1—malignant glioma	8.29e-05	0.000156	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2C18—malignant glioma	8.12e-05	0.000153	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—malignant glioma	8.01e-05	0.00015	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH1—malignant glioma	7.99e-05	0.00015	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SPHK1—malignant glioma	7.73e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2C18—malignant glioma	7.57e-05	0.000142	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—malignant glioma	6.7e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—malignant glioma	6.57e-05	0.000123	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—malignant glioma	6.54e-05	0.000123	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS1—malignant glioma	6.15e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—malignant glioma	6.12e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS1—malignant glioma	5.74e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCHE—malignant glioma	5.72e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—malignant glioma	5.65e-05	0.000106	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—malignant glioma	5.48e-05	0.000103	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCHE—malignant glioma	5.33e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—malignant glioma	5.27e-05	9.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	5.21e-05	9.78e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.85e-05	9.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—malignant glioma	4.55e-05	8.55e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAT—malignant glioma	4.43e-05	8.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—malignant glioma	4.24e-05	7.97e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOR1—malignant glioma	4.18e-05	7.86e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAT—malignant glioma	4.13e-05	7.76e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOR1—malignant glioma	3.9e-05	7.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—malignant glioma	3.41e-05	6.41e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—malignant glioma	3.18e-05	5.97e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—malignant glioma	3.11e-05	5.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—malignant glioma	3e-05	5.63e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—malignant glioma	2.9e-05	5.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—malignant glioma	2.79e-05	5.25e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—malignant glioma	2.73e-05	5.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—malignant glioma	2.55e-05	4.78e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—malignant glioma	2.38e-05	4.47e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—malignant glioma	2.36e-05	4.43e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—malignant glioma	2.22e-05	4.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—malignant glioma	2.2e-05	4.13e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—malignant glioma	2.06e-05	3.86e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—malignant glioma	1.92e-05	3.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.45e-05	2.73e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.35e-05	2.54e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—malignant glioma	1.19e-05	2.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—malignant glioma	1.1e-05	2.08e-05	CbGpPWpGaD
